The Enterprise Value as of June 2026 (TTM) for Prothena Corporation plc (PRTA) is 110.11M

According to Prothena Corporation plc’s latest financial reports and current stock price. The company's current Enterprise Value is 110.11M. This represents a change of -25.27% compared to the average of 147.34M of the last 4 quarters.

Prothena Corporation plc (PRTA) Historical Enterprise Value (quarterly & annually)

How has PRTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Prothena Corporation plc over the last ten years is 851.17M. The current 110.11M Enterprise Value has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), PRTA's Enterprise Value was at its highest in in the June 2023 quarter at 2.97B. The Enterprise Value was at its lowest in in the September 2019 quarter at -53348520.00.

Prothena Corporation plc (PRTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Prothena Corporation plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prothena Corporation plc (PRTA) Average Enterprise Value

How has PRTA Enterprise Value performed in the past?

The current Enterprise Value of Prothena Corporation plc (PRTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Prothena Corporation plc (PRTA) Enterprise Value vs. Peers

How is PRTA’s Enterprise Value compared to its peers?

Prothena Corporation plc’s Enterprise Value is less than KalVista Pharmaceuticals, Inc. (1.49B), greater than Bicycle Therapeutics plc (-264552133.00), less than 4D Molecular Therapeutics, Inc. (409.65M), less than Verastem, Inc. (204.11M), less than Olema Pharmaceuticals, Inc. (810.53M), less than Ventyx Biosciences, Inc. (982.56M), less than Neumora Therapeutics, Inc. Common Stock (183.14M), less than Corvus Pharmaceuticals, Inc. (963.93M), less than Gossamer Bio, Inc. (199.90M), less than Rigel Pharmaceuticals, Inc. (629.10M),

Build a custom stock screener for Prothena Corporation plc (PRTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prothena Corporation plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prothena Corporation plc (PRTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prothena Corporation plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.